🔥Patients with ILD experience delays in diagnosis. We interviewed patients and physicians to help understand why.

We need to advocate for:

- increased ILD awareness and education
-access to chest imaging
-earlier referral to respirology

bmjopenrespres.bmj.com/content/bmjres…
#curePF

Many thanks to all involved #pulmonaryfibrosis #CurePF

Had a great time speaking to students at Yale School of Public Health about impact of single cell technologies on respiratory disease. I always enjoy seeing the response to ChioccioliLab’s amazing moving type II cells clips, my cat insights &of course ending with dedication to #PFwarriors #CurePF

We discuss some of the challenges in design of an AE-IPF trial in this protocol paper for STRIVE-IPF study - an area of unmet need in #curePF and important considerations when developing novel adaptive trial platforms REMAP-ILD

bmcpulmmed.biomedcentral.com/articles/10.11…

Niche version for my #ILD tweeps
#CurePF #CureIPF #ILD #IPF

Evening meetings to discuss ILD? Why not! Peter George and Dr Voon Ong running a great talk on reuma disease associate ILDs ( and why we should not call them CTD- ILD anymore) #curePF

Thank you CHEST for this recognition- looking forward to another year of building tools to promote education in #curePF through CHEST ILD & Lung Transplant Network UAB Department of Medicine UAB Pulmonary

🚨ERS elections are open, and I am a candidate in the under-40 group for Assembly 12. 📨 thanks for supporting

You can vote on all open ERS positions by visiting myERS and selecting the ‘Elections’ tab. #ILD #ERS #curePF

Liam Galvin EU-PFF CEO chairs an exciting round table at the PF Summit on ‘clinical trials: exploring opportunities and insights’ with patient advocates, researchers and clinicians and pharma representatives. #pfSummit24 #curepf

We are up! You find me at the poster session, T-23 with Action for Pulmonary Fibrosis ERS Assembly 12 - ILD ERS Assembly 12 - ILD #ERSCongress2022 #CUREPF

I hope #ICLAF2022 will be remembered as the moment #CUREPF became possible.

So exciting to see #RemapILD develop from a #MedTwitter notion into a project in motion.

Kudos Leticia Kawano-Dourado Gisli Jenkins Wendy Adams @RogerJLewis Berry Consultants REMAP-ILD

#LetsKeepPushing

Dr. Naftali Kaminski delivers an outstanding lecture:

The Multi-Omic Universe. Integrating Datasets to Better Understand & #CurePF .

✔️Shows that nuclear sequencing reveals cell dissociation bias

✔️Surface density correlates with decline in AT-I & AT-II cells.

🫁
#ATS2023

Prof. Phillipe Camus (founder of pneumotox.com) takes us on a quick tour of drug-induced lung disease in an outstanding session.

Paid tribute to great clinicians in the past (William Osler, Edward Rosenow III, etc.)

#ERS2022 #CurePF #Pulmonaryfibrosisawarenessmonth

Please join us in congratulating Dr. Erica Herzog on her well-deserved promotion to Professor! #YalePCCSM #BestFaculty #PhysicianScientists #DoubleDocs #WomenInMedicine #CurePF medicine.yale.edu/profile/erica_…

Amazing worldview at #ATS2023 ! 🌎

⚡️Lung researchers from SIX different countries represented right here.⚡️

🇺🇸 🇦🇺 🇩🇪 🇳🇱 🇬🇧 🇮🇪

…all in the quest to #CurePF !

#ATS2023 #ATSSafe4All

Finally out! Our review “From #COVID19 to fibrosis: lessons from single-cell analyses of the human lung“. Kudos to Dr. Aurelien Justet and #FutureDoubleDoc Amy Zhao. #CurePF #scRNAseq humgenomics.biomedcentral.com/articles/10.11…

1/n Our first #CurePF paper for 2023 is OUT! A novel role in Pulmonary Fibrosis for miR-33, a key regulator of macrophage immuno-metabolic response & mitochondrial function, providing evidence that inhibition may be antifibrotic
#miR33PFPaper
doi.org/10.1172/jci.in…

Important from Dr. Spagnolo, Maher & teams - Will we be facing a wave of #COVID19 induced advanced lung diseases including #PulmonaryFibrosis ? I think we will. Time to think of #PostCOVID19PF #CureCOVID19 #CurePF thelancet.com/journals/lanre…

What’s more delightful than chilling out with ILD friends at Milan on a nice Italian summer evening! 🫁

#RestandRelaxation #ERS2023 #PulmonaryFibrosis #CurePF

Does it matter how far patients live from their ILD subspecialty clinic?

We hypothesized that patients from farther away would have more severe/late disease at initial referral, but found the opposite.

atsjournals.org/doi/abs/10.151…
#IPF #ILD #CurePF